OPTIC primary analysis: A dose-optimization study of 3 starting doses of ponatinib (PON) Meeting Abstract


Authors: Cortes, J. E.; Apperley, J. F.; Lomaia, E.; Moiraghi, B.; Sutton, M. U.; Pavlovsky, C.; Chuah, C.; Sacha, T.; Lipton, J. H.; McCloskey, J.; Hochhaus, A.; Rousselot, P.; Rosti, G.; De Lavallade, H.; Mauro, M. J.; Hall, T.; Lu, V.; Srivastava, S.; Deininger, M. W.
Abstract Title: OPTIC primary analysis: A dose-optimization study of 3 starting doses of ponatinib (PON)
Meeting Title: 9th Annual Meeting of the Society of Hematologic Oncology (SOHO)
Keywords: leukemia; tki; ponatinib; optic; t315i
Journal Title: Clinical Lymphoma, Myeloma and Leukemia
Volume: 21
Issue: Suppl. 1
Meeting Dates: 2021 Sep 8-11
Meeting Location: Virtual event
ISSN: 2152-2650
Publisher: Elsevier Inc.  
Date Published: 2021-09-01
Start Page: S328
Language: English
ACCESSION: WOS:000691910500207
PROVIDER: wos
DOI: 10.1016/s2152-2650(21)01769-9
Notes: Meeting Abstract: CML-129 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Michael John Mauro
    267 Mauro